ESTRO35 Programme Book

PRE-MEETING COURSES

Radiobiology track CLINICAL APPLICATION OF NEWCOMBINATIONS: HOWTO TEST AND OPTIMISE NOVEL BIOLOGICAL AGENTS IN COMBINATIONWITH RADIOTHERAPY 09:15 - 17:00 | LONDRA Course Directors: A. Chalmers (UK) and D. Zips (Germany)

INTRODUCTION AND OVERVIEW Course Director: A. Chalmers (UK)

09:15

INTRINSIC CELLULAR TARGETS, INCLUDING THE DNA DAMAGE RESPONSE AND ONCOGENIC SIGNALLING PATHWAYS A. Chalmers (UK) TUMOUR MICROENVIRONMENT TARGETS, INCLUDING HYPOXIA, VASCULATURE AND THE IMMUNE SYSTEM R. Bristow (Canada) PRECLINICAL EVALUATION OF NOVEL DRUG-RADIOTHERAPY COMBINATIONS: IN VITRO AND EARLY IN VIVO TESTING Teacher: C. Vens (The Netherlands) PRECLINICAL EVALUATION OF NOVEL DRUG-RADIOTHERAPY COMBINATIONS: COMPLEX IN VIVOMODELS Teacher: M. Baumann (Germany) CLINICAL TRIAL DESIGN: INCLUDING DOSE SELECTION, DOSE ESCALATION AND BIOMARKER DRIVEN STUDY DESIGNS Teacher: P. Lambin (The Netherlands) COFFEEBREAK

09:30

10:00

10:30

11:00

11:30

12:00

DISCUSSION

12:30

LUNCH

13:00

MOLECULAR BIOMARKERS FOR OPTIMISATION OF NOVEL RADIOTHERAPY-DRUG COMBINATIONS Teacher: D.G. Duda (USA) IMAGING BIOMARKERS FOR OPTIMISATION OF NOVEL RADIOTHERAPY-DRUG COMBINATIONS Course Director: D. Zips (Germany)

14:00

14:30

COFFEEBREAK

15:00

PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

42